Legend Biotech (LEGN) Amortization of Deferred Charges (2020 - 2025)
Legend Biotech's (LEGN) quarterly Amortization of Deferred Charges came in at $4.0 million in Q3 2025, up 42.64% YoY from $2.8 million in Q3 2024, and up 14.12% on a QoQ basis from $3.5 million in Q2 2025.
Legend Biotech (LEGN) Amortization of Deferred Charges (2020 - 2025) Analysis & Trends
Legend Biotech (LEGN) has 6 years of Amortization of Deferred Charges data on file, last reported at $4.0 million in Q3 2025.
- Quarterly Amortization of Deferred Charges rose 42.64% year-over-year to $4.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $13.0 million (up 43.79% YoY) and the FY2022 annual result came in at $5.7 million, up 30.55% from the prior year.
- Amortization of Deferred Charges grew to $4.0 million in Q3 2025, from $3.5 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $5.7 million in Q4 2022 to a low of $257000.0 in Q1 2022.
- A 5-year average of $2.2 million and a median of $2.2 million in 2024 frame the typical range for Amortization of Deferred Charges.
- The widest YoY moves for Amortization of Deferred Charges: up 525.21% in 2022, down 29.4% in 2022.
- Tracing LEGN's Amortization of Deferred Charges over 5 years: stood at $4.4 million in 2021, then soared by 30.55% to $5.7 million in 2022, then tumbled by 65.23% to $2.0 million in 2023, then soared by 39.06% to $2.8 million in 2024, then surged by 42.64% to $4.0 million in 2025.
- The last three Amortization of Deferred Charges figures came in at $4.0 million (Q3 2025), $3.5 million (Q2 2025), and $2.8 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.96 Mn |
| Sep 30, 2025 | 3.96 Mn |
| Jun 30, 2025 | 3.47 Mn |
| Jun 30, 2025 | 3.47 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Sep 30, 2024 | 2.78 Mn |
| Sep 30, 2024 | 2.78 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Mar 31, 2024 | 2.04 Mn |
| Mar 31, 2024 | 2.04 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | 5.74 Mn |
| Dec 31, 2022 | 5.74 Mn |